Episode 45: The Story of Cereproc and Speech Synthesis 🗯

What would you do with a cloned version of your voice? What if it sounded so real, it could turn text into jokes and even sing? What if someone cloned Her Majesty The Queen's voice? This week, James is joined by Dr. Matthew Aylett, a recognized world authority in speech technology research and development and was working at the International Computer Science Institute (ICSI) at Berkeley, California, before returning to Scotland in late-2005 to co-found CereProc. Matthew helps patients with conditions like throat cancers and neurological disorders to clone their voices and is exploring many other value propositions in health and healthtech. Prior to ICSI he was the senior development engineer at speech synthesis leader Rhetorical Systems (later acquired by Scansoft), which he joined at its formation. At Rhetorical, Matthew was responsible for the design, implementation, and testing of the company's core speech technology. Before Rhetorical, he spent five years at the University of Edinburgh researching speech and dialogue technologies. Dr. Matthew Aylett holds a BA in Computing and Artificial Intelligence from the University of Sussex, and an MSc with Distinction and PhD in Speech and Language Technology from the University Of Edinburgh. [email protected] | www.cereproc.com For more information and content, check out our website www.hs.ventures. You can follow us on Twitter @HSVenture, on Instagram @hs.ventures, on Linkedin at HS. and you can email us at [email protected]  You can get our host, Dr. James Somauroo, at www.jamessomauroo.com and you can follow him on Twitter @jamessomauroo, on Instagram @j_soms and on Linkedin at james-somauroo